Navigation Links
Interleukin Genetics to Host Third Quarter 2007 Financial Results Conference Call November 7
Date:11/2/2007

ntal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. Interleukin is headquartered in Waltham, MA. For more information about Interleukin and its ongoing programs, please visit http://www.ilgenetics.com.

Forward Looking Statements

Certain statements contained herein are "forward-looking" statements including statements regarding our ability to develop diagnostic, personalized nutritional and therapeutic products to prevent or treat diseases of inflammation and other genetic variations, our ability to screen nutritional compounds for their effects on inflammatory responses and other genetic variations, given specific genetic patterns, our ability to make progress in advancing our core technologies, and our expectations regarding fiscal year 2007 revenues and gross profit margins of our nutritional supplement products. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the risk of market acceptance of our products, the risk of technology and product obsolescence, delays in product development, the performance of our commercial partners, the availability of adequate capital, the actions of our competitors and other competitive risks, our ability to integrate acquired businesses, our ability to maintain relationships with our important customers, and those risks and uncertainties described in our annual report on Form 10-K for the year ended December 31, 2006 filed with the Securities and Exchange Commission, our quarterly reports on Form 10-Q and other filings made by us with the Securities and Exchange Commission. We disclaim any obligation or intention to update these forward-looking statements
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Diptheria Toxin And Interleukin2 Help Killing Melanoma Tumour Cells
2. Genetics and cholesterol levels
3. Genetics helps in attacking cancer
4. Alcoholism Influenced By Both Genetics & Family Environment
5. Genetics linked to leukemia treatment success rate in children
6. Genetics Has A Major Role To Play In Body Shape.
7. Revolution in Genetics to Open Avenues for Treating Cancer
8. AIDS research and genetics...
9. Faster way of producing Bird flu vaccine using Reverse Genetics
10. Genetics of Ageing with Preserved Mental Capacity.
11. Generation Scotland To Examine Relation Between Lifestyle, Genetics and Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Aon Consulting, the ... Corporation (NYSE: AON ), today ... as senior vice president with the Health ... national Pharmacy Practice. ,, (Logo: ... role, Zeitel will work under the direction ...
(Date:12/15/2009)... The following is being released by the ... by: Vera Rulon, MS, RHIT, CCS, FAHIMA ,, ... thank you joining us... ,, On behalf of the ... introduce our next chief executive officer, Doctor Alan Dowling... ... nationwide search for someone who we knew ...
(Date:12/15/2009)... A new study published by The University of ... for paid and unpaid work report higher average measures ... family models. , The ,shared roles, category, where each ... the total unpaid work, is a growing category that ... Couples are more likely to be in a shared ...
(Date:12/15/2009)... invisible hearing protection that allows users to control the volume ... ... Washington, DC (PRWEB) Dec. 15, 2009 -- EarPeace ( ... ear plugs that are available in three different skin-tone colors. ... a measure of my hearing, I was looking for a ...
(Date:12/15/2009)... fiber , , TUESDAY, Dec. 15 (HealthDay News) -- The chances ... are much lower on playgrounds with granite sand surfaces than ... , Researchers at the Hospital for Sick Children in Toronto ... granite sand or engineered wood fiber. Their findings were reported ... risk of a broken arm resulting from a fall from ...
Breaking Medicine News(10 mins):Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 2Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 3Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 4Health News:Dowling Press Availability Tuesday, December 15, 2009 / 10:00 a.m. CST 2Health News:EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution 2
... Chief Minister Manik Sarkar inaugurated the Tripura Medical ... run medical college-cum-hospital in India's northeastern// region. ... Net (GENET) in collaboration with the state government, ... in the healthcare education in India," said K. ...
... in a small duck farm in the southern province of ... health official from Thach Phu district, Ben Tre province said, ... H5N1 virus." All 84 ducks on the farm were ... farms tested negative for the virus. ,The official ...
... suggested that people with advanced heart disease have arteries that ... ,In a study conducted by ... and transplant patients to study how artery cells age. ... seven to 13 times more rapidly than normal in a ...
... human genome to date linked to the identifiction of people ... researchers at// the Molecular Neurobiology Branch of the National Institute ... be the first time that the new genomic technology has ... The results of the study can be viewed online and ...
... and instigate them to self-harm, ultimately causing death of cancer ... ,This discovery works on the known ... to check the abnormal growth of cells; the way to ... themselves. This natural process, termed as apoptosis, involves he ...
... is indeed an important milestone in the development of strategies ... cervical cancer, named Gardasil, has// made it to the market. ... Frazer, a scientist in Queens land and the brain behind ... it since 1990, is all set to administer the inaugural ...
Other Medicine News:Health News:Study to Identify People at Risk of Alcoholism 2Health News:Study to Identify People at Risk of Alcoholism 3
(Date:12/15/2009)... NEW YORK, Dec. 15 Reportlinker.com ... is available in its catalogue: ,, ... http://www.reportlinker.com/p0168539/Boehringer-Ingelheim-GmbH-PharmaVitae-Profile.html ,, Introduction ... forecast performance for Boehringer Ingelheim in the ... strategy, portfolio and pipeline analysis and assessment ...
(Date:12/15/2009)... Dec. 15 At today,s regular meeting of ... LZ ), the board declared a regular ... 10, 2010 to holders of record at the close ... The Lubrizol Corporation ,, The Lubrizol Corporation (NYSE: ... company that produces and supplies technologies that improve the ...
(Date:12/15/2009)... 15 Today, Hill-Rom Holdings, Inc. (NYSE: ... progress on significant strategic and financial initiatives at ... The Conference is hosted by Peter H. Soderberg, ... presentations on the following topics: ,, Status ... and development and financial updates Smart technologies ...
Breaking Medicine Technology:Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 2Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 3Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 4Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 5Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 6Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile 7Lubrizol Declares Dividend 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Getting College Students To Wash Hands Halt Disease Requires Giving Them Proper Tools and Spreading The Word In Ways That Get Attention Say K State 56268 1Getting College Students To Wash Hands Halt Disease Requires Giving Them Proper Tools and Spreading The Word In Ways That Get Attention Say K State 56268 2Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 56266 1Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 56266 2Partnership for Prescription Assistance Prepared to Help Kentucky Workers Hurt by Recession 56266 3Surgical scrub solution 3A Its good for patients too 56263 1Surgical scrub solution 3A Its good for patients too 56263 2Surgical scrub solution 3A Its good for patients too 56263 3Surgical scrub solution 3A Its good for patients too 56263 4
... Class, of Stent with Polyzene(R)-F Surface ... for Long-Term,Dual Antiplatelet Therapy, WASHINGTON, ... today,s,"Innovative Devices and Futuristic Therapies" session ... (TCT) scientific,symposium, sponsored by the Cardiovascular ...
... in Combination with Chemotherapy, FREMONT, Calif. ... pharmaceutical company discovering and developing novel,RNA interference ... Research published results on efficacy of siRNA ... lung cancer (NSCLC) in,the edition dated October ...
Other Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4
... The S7 gives enhanced deliverability ... Platform gives your short-wire capability and ... catheters. Secure Technology Stent Retention ... Discrete Technology designed to minimize balloon ...
The MULTI-LINK RX PENTA Coronary Stent Systems with new ACCESS-LINK Stent Design are indicated for improving coronary luminal diameter....
The MULTI-LINK ZETA Over the Wire Coronary Stent System utilizes the same clinically proven implant as the MULTI-LINK PENTA Coronary Stent System, maintaining the benefits of a 17.5% binary restenosi...
Now available in 2.75-mm diameters, the S660 small vessel coronary stent expands your treatment options for accurate sizing and precision stenting....
Medicine Products: